Breast Cancer

Latest News

Patient satisfaction was higher amongst women who underwent chest wall perforator flap technique when compared with other techniques.| Image Credit: AdobeStock_ H_Ko.jpeg
Patient Satisfaction Higher With Certain Breast Reconstruction Techniques

August 12th 2025

Patient satisfaction was higher amongst patients who underwent a chest wall perforator flap reconstruction surgery as part of their breast cancer treatment when compared with other surgical techniques.

Supplemental breast cancer screenings criteria leaves Black women ineligible despite high percentage of false-negative mammograms. | Image Credit: breastcancerscreening-H_Ko.jpeg
Supplemental Breast Cancer Screening Law Renders Many High-Risk Black Women Ineligible

August 5th 2025

Black women are at a higher risk for breast cancer mortality due to social determinants of health and lack of inclusivity in breast cancer genome research. | Image credit: Stafeeva - stock.adobe.com.jpeg
Social Disparities Increase Breast Cancer Mortality for Black Women

July 27th 2025

Early-onset breast cancer found to be associated with certain hormone therapy usage in younger women. | Image Credit: Chinnapong - stock.adobe.com
Hormone Therapy Use May Impact Early-Onset Breast Cancer Risk

July 26th 2025

Menopausal hormone therapy is associated with a higher risk of developing certain breast cancer subtypes. | Image Credit: vectorfusionart - stock.adobe.com
Hormone Therapy Use Differentially Associated With Breast Cancer Subtypes

July 16th 2025

Advances in CDK4/6 Inhibitor Use in High-Risk Early Breast Cancer: 2024 Updates

Experts discuss the impact of CDK4/G inhibitor use, including medication cost, total care costs, toxicity profiles, and strategies to manage and optimize patient outcomes in high-risk early breast cancer.

Watch the latest AJMC Peer Exchange on Advances in CDK4/6 Inhibitor Use in High-Risk Early Breast Cancer: 2024 Updates

More News

center for biosimilars
August 17th 2020

Choice Is Vital to Biosimilar Savings Picture, Panelists Say

Tony Hagen
The challenges of complying with payer mandates in biosimilars were discussed in a webinar sponsored by The American Journal of Managed Care® and The Center for Biosimilars®.
Screening for Breast Cancer at Younger Ages Linked to Reduced Mortality
August 14th 2020

Screening for Breast Cancer at Younger Ages Linked to Reduced Mortality

Maggie L. Shaw
Screening women aged 40 to 49 years for breast cancer reduced mortality by 25% in the first 10 years compared with waiting until at age 50 years and older, which is the common practice in the United Kingdom.
Are There Benefits to Awake Breast Cancer Surgery During COVID-19?
August 11th 2020

Are There Benefits to Awake Breast Cancer Surgery During COVID-19?

Maggie L. Shaw
In Italy, a study looked at reallocating resources meant for patients with breast cancer to those stricken with coronavirus disease 2019, finding that the former could benefit from fast-track awake surgery to reduce risk of cross-infection.
Survival Consistent for Women With Early-Stage Breast Cancer Despite Surgery Delays
August 7th 2020

Survival Consistent for Women With Early-Stage Breast Cancer Despite Surgery Delays

Maggie L. Shaw
Delays in surgery to treat early-stage breast cancer and receiving neoadjuvant endocrine therapy did not decrease survival odds among female patients, authors report in the Journal of the American College of Surgeons.
Global Incidence of Premenopausal, Postmenopausal Breast Cancer Rising
August 3rd 2020

Global Incidence of Premenopausal, Postmenopausal Breast Cancer Rising

Maggie L. Shaw
Higher-income countries are seeing their rates of premenopausal breast cancer increase faster, whereas cases of postmenopausal breast cancer are increasing in number faster in lower-income studies.
Mortality Among Men With Breast Cancer Decreases With Adjuvant Chemotherapy
July 30th 2020

Mortality Among Men With Breast Cancer Decreases With Adjuvant Chemotherapy

Maggie L. Shaw
Less than 1% of all breast cancers occur in men, making this a rare disease among that patient population, and most treatment guidelines are based on outcomes and survival rates seen in women with the disease.
Women With Extremely Dense Breast Tissue May Not Benefit From 3-D Mammography
July 28th 2020

Women With Extremely Dense Breast Tissue May Not Benefit From 3-D Mammography

Maggie L. Shaw
Compared with digital mammography, digital breast tomosynthesis, also called 3-dimensional (3-D) mammography, has been proven superior at effectively detecting breast cancer and leading to fewer recall visits, but more information is needed for how subgroups of women with different breast densities benefit from the screening method, especially those classified as having extremely dense breast tissue.
Germline BRCA-Mutated Breast Cancer Does Not Increase Risk of Adverse Pregnancy Outcomes
July 23rd 2020

Germline BRCA-Mutated Breast Cancer Does Not Increase Risk of Adverse Pregnancy Outcomes

Maggie L. Shaw
Women with early-onset germline BRCA-mutated breast cancer can have subsequent pregnancies without increasing their risk for disease recurrence, according to the authors of a recent study in Journal of Clinical Oncology.
Diagnostic Delays From COVID-19 May Increase Cancer-Related Deaths, UK Studies Say
July 21st 2020

Diagnostic Delays From COVID-19 May Increase Cancer-Related Deaths, UK Studies Say

Maggie L. Shaw
The next several years could bear witness to thousands of additional deaths from cancer that could have been prevented through routine diagnostic care that was delayed because of the coronavirus disease 2019 (COVID-19) pandemic, according to a pair of studies in The Lancet Oncology.
Male Breast Cancer Survival Similar to That in Women Despite Treatment Variation
July 17th 2020

Male Breast Cancer Survival Similar to That in Women Despite Treatment Variation

Maggie L. Shaw
Because male breast cancer is such a rare disease, few strides have been made that convey advantages in its detection, incidence, and mortality. Most treatment guidelines have been extracted from studies performed among female patients.
Interval Breast Cancer Found Within 1 Year Linked to Worse Mortality
July 14th 2020

Interval Breast Cancer Found Within 1 Year Linked to Worse Mortality

Maggie L. Shaw
Breast cancer diagnosed in the year following a negative result after a mammogram has now been associated with an increase in mortality compared with breast cancer detected at a screening, report JAMA Network Open study results.
Smoking History May Influence Adverse Outcomes Following Radiotherapy for Breast Cancer
July 9th 2020

Smoking History May Influence Adverse Outcomes Following Radiotherapy for Breast Cancer

Maggie L. Shaw
Smoking history can both increase the risk of cancer and create a hypoxic environment within the body, leading to poor outcomes, including less-effective treatment, among patients who undergo radiotherapy.
Can Early Screening Reduce Breast Cancer Mortality Among Childhood Cancer Survivors?
July 7th 2020

Can Early Screening Reduce Breast Cancer Mortality Among Childhood Cancer Survivors?

Gianna Melillo
In survivors of childhood cancer, early initiation of annual breast cancer screening with MRI, with or without mammography, may reduce breast cancer mortality by half or more, according to a study published in Annals of Internal Medicine.
Study Results Show Possible Link Between Medicaid Expansion, Drop in Advanced Breast Cancer
July 1st 2020

Study Results Show Possible Link Between Medicaid Expansion, Drop in Advanced Breast Cancer

Maggie L. Shaw
Despite ongoing disparities in the use of health care services among races/ethnicities and ages, as well as by insurance status, African American women with advanced breast cancer benefited the most following implementation of the Affordable Care Act in states that chose to expand Medicaid coverage.
Closing Thoughts on Metastatic Breast Cancers
July 1st 2020

Closing Thoughts on Metastatic Breast Cancers

Assessing the Value of Personalized Treatment in mBC
July 1st 2020

Assessing the Value of Personalized Treatment in mBC

Considerations for NGS Testing in mTNBC
July 1st 2020

Considerations for NGS Testing in mTNBC

Treatment Options in Metastatic TNBC
July 1st 2020

Treatment Options in Metastatic TNBC

Role of PARP Inhibition and I/O Therapy in TNBC
July 1st 2020

Role of PARP Inhibition and I/O Therapy in TNBC

IMpassion130 Trial Data on PD-L1+ Tumors in TNBC
July 1st 2020

IMpassion130 Trial Data on PD-L1+ Tumors in TNBC

Sequencing of Therapy in R/R HER2+ mBC
July 1st 2020

Sequencing of Therapy in R/R HER2+ mBC

SOPHIA Trial in R/R HER2+ mBC
July 1st 2020

SOPHIA Trial in R/R HER2+ mBC

HER2CLIMB and NALA Trials: R/R HER2+ mBC
July 1st 2020

HER2CLIMB and NALA Trials: R/R HER2+ mBC

Evolving Treatment Landscape of R/R HER2+ mBC
July 1st 2020

Evolving Treatment Landscape of R/R HER2+ mBC

Payer Coverage of IV Versus Oral Therapy in mBC
July 1st 2020

Payer Coverage of IV Versus Oral Therapy in mBC

Compliance and Adherence to Therapy in mBC
July 1st 2020

Compliance and Adherence to Therapy in mBC

Advantages of Oral Taxanes in mBC
July 1st 2020

Advantages of Oral Taxanes in mBC

Payer Coverage on Repeat Biopsy in mBC
July 1st 2020

Payer Coverage on Repeat Biopsy in mBC

Payer Perspective of Coverage on Cancer Therapies
July 1st 2020

Payer Perspective of Coverage on Cancer Therapies

SOLAR-1 Trial in Metastatic Breast Cancer
July 1st 2020

SOLAR-1 Trial in Metastatic Breast Cancer

<1
...
678910111213>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo